These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9833555)

  • 1. [Hemophilia B with inhibitor].
    Takahashi I
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):502-5. PubMed ID: 9833555
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hemophilia].
    Straub PW
    Dtsch Med Wochenschr; 1969 Sep; 94(37):1885-7. PubMed ID: 5356323
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advances in the field of hemophilia therapy].
    Loeliger EA; Veltkamp JJ
    Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutant macaque factor IX T262A: a tool for hemophilia B gene therapy studies in macaques.
    Ishiwata A; Mimuro J; Mizukami H; Kashiwakura Y; Yasumoto A; Sakata A; Ohmori T; Madoiwa S; Ono F; Shima M; Yoshioka A; Ozawa K; Sakata Y
    Thromb Res; 2010 Jun; 125(6):533-7. PubMed ID: 20170943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus on hemophilia in Mexico.
    López-Arroyo JL; Pérez-Zúñiga JM; Merino-Pasaye LE; Saavedra-González A; Alcivar-Cedeño LM; Álvarez-Vera JL; Anaya-Cuellar I; Arana-Luna LL; Ávila-Castro D; Bates-Martín RA; Cesarman-Maus G; Chávez-Aguilar LA; de la Peña-Celaya JA; Espitia-Ríos ME; Estrada-Domínguez P; Fermín-Caminero D; Flores-Patricio W; Chávez JG; García-Lee MT; González-Pérez MDC; González-Rubio MDC; González-Villareal MG; Ramírez-Moreno F; Hernández-Colin AK; Hernández-Ruiz E; Herrera-Olivares W; Leyto-Cruz F; Loera-Fragoso S; Martínez-Ríos A; Miranda-Madrazo MR; Morales-Hernández A; Nava-Villegas L; Orellana-Garibay JJ; Palma-Moreno OG; Paredes-Lozano EP; Peña-Alcántara P; Pérez-Lozano U; Pichardo-Cepín YM; Reynoso-Pérez AC; Rodríguez-Serna M; Rojas-Castillejos F; Romero-Rodelo H; Ruíz-Contreras JI; Segura-García A; Silva-Vera K; Soto-Cisneros PM; Tapia-Enríquez AL; Tavera-Rodríguez MG; Teomitzi-Sánchez Ó; Tepepa-Flores F; Valencia-Rivas MD; Valle-Cárdenas T; Varela-Constantino A; Javier-Morales A; Martínez-Ramírez MA; Tena-Cano S; Terrazas-Marín R; Vilchis-González SP; Villela-Peña A; Mena-Zepeda V; Ibarra MA
    Gac Med Mex; 2021; 157(Supl 1):S1-S37. PubMed ID: 33588427
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acquired haemophilia B: a case report and literature review].
    Jedidi I; Hdiji S; Ajmi N; Makni F; Masmoudi S; Elloumi M; Kallel C
    Ann Biol Clin (Paris); 2011; 69(6):685-8. PubMed ID: 22123568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology evaluation: AAV factor IX gene therapy, Avigen Inc.
    Fabb SA; Dickson JG
    Curr Opin Mol Ther; 2000 Oct; 2(5):601-6. PubMed ID: 11249763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9.
    Fields PA; Arruda VR; Armstrong E; Chu K; Mingozzi F; Hagstrom JN; Herzog RW; High KA
    Mol Ther; 2001 Sep; 4(3):201-10. PubMed ID: 11545610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical operation in hemophilia B. Use of factor IX concentrate.
    Kasper CK
    Calif Med; 1970 Jul; 113(1):4-8. PubMed ID: 5520728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genotyping of the Italian cohort of patients with hemophilia B.
    Belvini D; Salviato R; Radossi P; Pierobon F; Mori P; Castaldo G; Tagariello G;
    Haematologica; 2005 May; 90(5):635-42. PubMed ID: 15921378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation factor IX inhibitor in hemophilia B].
    Lutze G; Mittler U; Presser HJ; Urbahn H
    Z Med Lab Diagn; 1990; 31(2):113-9. PubMed ID: 2343619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ulcerative colitis and hemophilia B].
    Rodríguez Cuartero A; González Martínez F; Salas Galán A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):573-4. PubMed ID: 9303627
    [No Abstract]   [Full Text] [Related]  

  • 13. [Factor IX and factor IX inhibitor].
    Higasa S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():647-50. PubMed ID: 15658413
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelets: a new target for gene therapy of haemophilia B.
    Brown MA
    Thromb Haemost; 2002 Mar; 87(3):362-3. PubMed ID: 11916064
    [No Abstract]   [Full Text] [Related]  

  • 15. Prosthetic heart valves and rare hypersensitivity to vitamin K antagonists resulting from factor IX mutation: how to manage anticoagulation?
    Holbro A; Marbet GA; Tran TH; Oldenburg J; Friesewinkel O; Tsakiris DA
    Haemophilia; 2010 Jan; 16(1):187-9. PubMed ID: 19804386
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of F.IX-inhibitor bypassing activity contained in a commercial prothrombin complex concentrate (Proplex)].
    Sugimoto M; Fujimura Y; Okubo Y; Takahashi Y; Yoshioka A; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1984 Aug; 47(5):1181-9. PubMed ID: 6516702
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor IX: Insights from knock-out and genetically engineered mice.
    Monahan PE
    Thromb Haemost; 2008 Oct; 100(4):563-75. PubMed ID: 18841277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual presentation of hemophilia B: pseudotumor of proximal tibia.
    Mittal S; Arora S; Khanna S; Maini L; Gautam VK
    Am J Orthop (Belle Mead NJ); 2011 Jul; 40(7):E138-40. PubMed ID: 22013580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Clinical concentrates of clotting-factor IX.
    Lancet; 1975 Nov; 2(7940):855-6. PubMed ID: 53334
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular diagnosis in patients and carriers of hemophilia A and B].
    Mantilla-Capacho J; Beltrán-Miranda CP; Jaloma-Cruz AR
    Gac Med Mex; 2005; 141(1):69-71. PubMed ID: 15754755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.